Page last updated: 2024-08-24

capecitabine and Biliary Tract Cancer

capecitabine has been researched along with Biliary Tract Cancer in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	15 (23.81)	29.6817
2010's	27 (42.86)	24.3611
2020's	21 (33.33)	2.80

Authors

Authors	Studies
Firth, C; Hsu, K; Ikeda, M; Javle, MM; Lindmark, B; McIntyre, N; Oh, DY; Yong, WP	1
Anthony, A; Bridgewater, J; Corrie, P; Cunningham, D; Davidson, B; Evans, TR; Falk, S; Finch-Jones, M; Fletcher, P; Garden, OJ; Iveson, T; Ma, YT; Malik, HZ; Mirza, D; Neoptolemos, J; Palmer, DH; Prasad, R; Praseedom, R; Primrose, J; Ross, P; Stocken, D; Stubbs, C; Valle, JW; Wadsley, J; Wall, L; Wasan, H	1
Edeline, J; Malka, D	2
Abadi, S; Davies, JM; Ho, C; Mathers, B; McIntyre, C	1
Aktas, BY; Akyildiz, A; Chalabiyev, E; Dizdar, O; Guven, DC; Kus, F; Yalcin, S; Yasar, S; Yildirim, HC; Yilmaz, F	1
Belkouz, A; de Reuver, PR; de Savornin Lohman, E; Groot Koerkamp, B; Klümpen, HJ; Nathan, H; Punt, CJA; Thumma, JR; van Oijen, MGH	1
Gotohda, N; Hatano, E; Kawamoto, Y; Nakachi, K; Nara, S; Takahashi, S; Ueno, M	1
Asselah, J; Chaudhury, P; Chhiber, N; Doucette, S; Goodwin, R; Knox, JJ; Lim, HJ; Ramjeesingh, R; Roberge, D; Tam, VC	1
Edeline, J	1
Anker, CJ; Buckstein, MH; Hallemeier, CL; Huguet, F; Jabbour, SK; Kharofa, J; Olsen, JR; Tait, D	1
Baron, AD; Barzi, A; Bekaii-Saab, TS; El-Khoueiry, AB; Guthrie, KA; Hochster, H; Javle, M; Keogh, GP; Kim, EJ; Kim, RD; McDonough, S; Sahai, V; Siegel, AB; Stein, SM	1
Belkouz, A; de Vos-Geelen, J; Dejong, CHC; Groot Koerkamp, B; Hagendoorn, J; Haj Mohammad, N; Homs, MYV; Klümpen, H; Punt, CJA; van Gulik, TM; van Oijen, MGH; Wilmink, JW	1
Gamboa, AC; Maithel, SK	1
Bartoli, L; Messori, A; Trippoli, S	1
Akhoundova Sanoyan, D; Lamarca, A; McNamara, MG; Valle, JW	1
Jin, J; Zhang, Y; Zheng, T; Zhou, L	1
Ban, D; Esaki, M; Furuse, J; Ioka, T; Ishii, H; Nara, S; Okusaka, T; Shimada, K; Takamoto, T	1
Brandi, G; Rizzo, A	2
Carrato, A; Feliu, J; Garcia-Carbonero, R; Gómez-España, MA; Martín, AM; Maurel, J; Mercadé, TM; Montes, AF; Pazo-Cid, R; Vera, R	1
Ahmed, O; Ahmed, S; Sutherland, M; Zaidi, A	1
Bang, S; Cho, IR; Chung, MJ; Jo, JH; Jung, JH; Lee, HS; Park, JY; Park, SW; Song, SY	1
Diness, LV; Larsen, FO; Markussen, A; Nielsen, D	1
Abdel-Rahman, O; Elhalawani, H; Elsayed, Z	1
Choi, HJ; Hong, JH; Jang, JS; Kang, JH; Kim, MJ; Kim, S; Kim, ST; Lee, HW; Lee, J; Lee, MA; Lim, HY; Oh, SY; Park, JO; Park, YS; Sohn, BS; Yoon, SY	1
Bachini, M; Bekaii-Saab, T; Crane, C; Edeline, J; El-Khoueiry, A; Feng, M; Katz, MHG; Kennedy, EB; Maithel, SK; Primrose, J; Shroff, RT; Soares, HP; Valle, J	1
Anthony, A; Bridgewater, J; Corrie, P; Cunningham, D; Davidson, B; Evans, JTR; Falk, S; Finch-Jones, M; Fox, RP; Garden, OJ; Iveson, T; Ma, YT; Malik, HZ; Mirza, D; Neoptolemos, JP; Palmer, DH; Prasad, R; Praseedom, R; Primrose, JN; Raftery, J; Ross, P; Stocken, D; Stubbs, C; Valle, JW; Wadsley, J; Wall, L; Wasan, H; Zhu, S	1
Budai, B; Ganofszky, E; Hitre, E; Horváth, Z; Juhos, E; Láng, I; Nagy, T; Rubovszky, G; Szabó, E; Szentirmay, Z	1
Beijnen, JH; Cerny, T; Gillessen, S; Hitz, F; Huitema, AD; Joerger, M; Koeberle, D; Rosing, H; Schellens, JH	1
Han, SS; Hong, EK; Kim, DH; Kim, JH; Kim, TH; Koh, YH; Lee, JH; Lee, WJ; Park, SJ; Woo, SM	1
Fiaschi, AI; Francini, E; Laera, L; Marrelli, D; Petrioli, R; Roviello, F; Roviello, G	1
Hoegdall, E; Nielsen, D; Ole Larsen, F; Taksony Solyom Hoegdall, D	1
Barucca, V; D'Antonio, C; Falcone, R; Marchetti, P; Milano, A; Onesti, CE; Palombi, L; Righini, R; Roberto, M; Romiti, A	1
Aldrighetti, L; Aprile, G; Auriemma, A; Belli, C; Cereda, S; Cordio, S; Galiano, A; Leone, F; Lutrino, SE; Marino, D; Martines, C; Milella, M; Mosconi, S; Novarino, A; Palazzo, V; Reinach, B; Reni, M; Santini, D; Vaccaro, V; Vasile, E	1
Bradshaw-Pierce, EL; Eckhardt, SG; Eppers, S; Freas, E; Kane, MA; Kessler, ER; Leong, S; Lieu, CH; Messersmith, WA; Nallapreddy, S; O'byrant, CL; Pitts, TM; Spratlin, J; Weekes, C	1
Boyd, K; Bützberger-Zimmerli, P; Coxon, FY; Eatock, MM; Evans, TR; Graham, JS; Harden, S; Highley, M; Maughan, TS; Soulis, E; Wall, LR	1
Chang, HM; Kim, KP; Park, K; Park, S	1
Grande, C; Groman, A; Iancu, DM; Iyer, RV; Ma, WW; Malhotra, U; Pokuri, VK; Saab, TB	1
Chang, HM; Hyung, J; Kim, BJ; Kim, KP; Park, SJ; Ryoo, BY; Yoo, C	1
Brenner, WS; Fournier, C; Fracasso, PM; Gao, F; James, J; Marsh, S; McLeod, HL; Picus, J; Tan, BR; Yen-Revollo, JL	1
Beretta, K; Borner, M; Caspar, CB; Dietrich, D; Gerber, D; Herrmann, R; Koeberle, D; Mingrone, W; Mora, O; Ruhstaller, T; Saletti, P; Strasser, F	1
Bang, YJ; Heo, DS; Im, SA; Kim, DW; Kim, MJ; Kim, TY; Lee, SH; Oh, DY	1
Bria, E; Carlini, P; Carpanese, L; Cognetti, F; De Marco, S; Gelibter, A; Milella, M; Nuzzo, C; Pino, MS; Ruggeri, EM; Sperduti, I	1
Cantore, M; Danesi, R; Del Freo, A; Del Tacca, M; Giovannetti, E; Mambrini, A; Nannizzi, S; Orlandi, M; Pacetti, P; Tartarini, R	1
Bisegna, R; Bonfili, P; Bratta, M; Candeloro, G; Necozione, S; Rea, S; Recchia, F; Sica, G; Tombolini, V	1
Anderson, H; Glimelius, B; Gunnlaugsson, A; Johnsson, A; Lind, P	1
Bergsland, EK; Coakley, FV; Dito, E; Espinoza, AM; Hanover, CS; Jones, KA; Kelley, RK; Ko, AH; Ong, A; Tempero, MA; Venook, AP	1
Bronte, G; Catalano, V; Falcone, A; Graziano, F; Masi, G; Russo, A; Santini, D; Tonini, G; Vasile, E; Vincenzi, B; Virzi, V	1
Hansen, TF; Jakobsen, A; Jensen, LH; Lindebjerg, J; Ploen, J	1
Furuse, J; Kasuga, A; Kitamura, H; Nagashima, F; Takasu, A	1
Han, SS; Hong, EK; Kim, CM; Kim, HB; Kim, TH; Koh, YH; Lee, WJ; Park, JW; Park, SJ; Woo, SM	1
Deming, DA; Goggins, T; Groteluschen, D; Hernan, HR; Holen, KD; LoConte, NK; Lubner, SJ; Mulkerin, DL; Oettel, K; Robinson, E; Schelman, WR; Traynor, AM	1
Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B	1
Chang, YS; Cho, JY; Chung, JB; Lee, DK; Lee, SJ; Paik, YH; Park, MS; Song, SY; Yoon, DS; Yu, JS	1
Bang, SM; Cho, EK; Lee, JH; Lee, JN; Park, SH; Park, YH; Shin, DB	1
Ikeda, M; Morizane, C; Okusaka, T; Ueno, H	1
Berrios, M; Cordova, A; de Aretxabala, X; Gallardo, J; Hepp, J; Leon, J; Maluenda, F; Roa, I; Roa, JC	1
Choi, SH; Heo, JS; Hong, YS; Hwang, IG; Kang, WK; Lee, J; Lee, SC; Lim, HY; Park, JO; Park, YS	1
Chin, SN; Knox, JJ; Pond, GR; Riechelmann, RP; Townsley, CA	1
Cantore, M; Del Freo, A; Fiorentini, G; Mambrini, A; Orlandi, M; Pacetti, P; Torri, T	1
Gregor, M; Hartmann, JT; Hass, HG; Hochhaus, A; Hofheinz, RD; Horger, MS; Klump, B; Koppenhöfer, U; Nehls, O; Oettle, H; Stieler, J; Trojan, J	1

Reviews

17 review(s) available for capecitabine and Biliary Tract Cancer

Article	Year
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy, 2023, Volume: 23, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Gemcitabine; Humans; Liver Neoplasms	2023
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials. Japanese journal of clinical oncology, 2023, Nov-05, Volume: 53, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Humans; Neoadjuvant Therapy; Randomized Controlled Trials as Topic	2023
[Adjuvant treatment of biliary tract cancers: Who and how?] Bulletin du cancer, 2020, Volume: 107, Issue:1 Topics: Antineoplastic Agents; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Deoxycytidine; Gallbladder Neoplasms; Gemcitabine; Humans; Intention to Treat Analysis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome	2020
Gastrointestinal Cancers: Moving the Needle for Rectal, Gastroesophageal, Pancreaticobiliary, and Liver Cancers. International journal of radiation oncology, biology, physics, 2020, 03-15, Volume: 106, Issue:4 Topics: Biliary Tract Neoplasms; Capecitabine; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Rectum	2020
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. Critical reviews in oncology/hematology, 2020, Volume: 151 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Neoplasm Recurrence, Local; Prospective Studies	2020
The Landmark Series: Gallbladder Cancer. Annals of surgical oncology, 2020, Volume: 27, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Gallbladder Neoplasms; Humans; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Retrospective Studies	2020
Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives. Current opinion in oncology, 2020, Volume: 32, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Drug Combinations; Gemcitabine; Humans; Multicenter Studies as Topic; Oxaliplatin; Oxonic Acid; Randomized Controlled Trials as Topic; Tegafur	2020
Comparison between Fluoropyrimidine-Cisplatin and Gemcitabine-Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Meta-Analysis. Oncology research and treatment, 2020, Volume: 43, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult	2020
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. Japanese journal of clinical oncology, 2020, Dec-16, Volume: 50, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Gemcitabine; Humans; Neoadjuvant Therapy; Oxonic Acid; Tegafur	2020
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care. Expert review of gastroenterology & hepatology, 2021, Volume: 15, Issue:5 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Humans; Randomized Controlled Trials as Topic	2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions. Cancer treatment and research communications, 2021, Volume: 27 Topics: Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Deoxycytidine; Disease-Free Survival; Follow-Up Studies; Gemcitabine; Humans; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Review Literature as Topic; Standard of Care	2021
Current progress in systemic therapy for biliary tract cancers. Journal of hepato-biliary-pancreatic sciences, 2022, Volume: 29, Issue:10 Topics: B7-H1 Antigen; Biliary Tract Neoplasms; Capecitabine; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasm Recurrence, Local	2022
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. The Cochrane database of systematic reviews, 2018, Apr-06, Volume: 4 Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Drug Combinations; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Piperidines; Quinazolines; Randomized Controlled Trials as Topic; Tegafur	2018
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 04-20, Volume: 37, Issue:12 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Evidence-Based Medicine; Gemcitabine; Humans; Oxaliplatin; Practice Guidelines as Topic; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retrospective Studies	2019
Role of chemotherapy in treatments for biliary tract cancer. Journal of hepato-biliary-pancreatic sciences, 2012, Volume: 19, Issue:4 Topics: Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2012
[5 -fluoropyrimidines for treatment of biliary tract cancers]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Oxonic Acid; Pyridines; Pyrimidines; Tegafur; Uracil	2006
Chemoradiotherapy in gallbladder cancer. Journal of surgical oncology, 2006, Jun-15, Volume: 93, Issue:8 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Neoadjuvant Therapy; Palliative Care; Survival Analysis	2006

Trials

28 trial(s) available for capecitabine and Biliary Tract Cancer

Article	Year
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp). ESMO open, 2022, Volume: 7, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Double-Blind Method; Female; Humans; Progression-Free Survival	2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 06-20, Volume: 40, Issue:18 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Humans; Prognosis	2022
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer. European journal of cancer (Oxford, England : 1990), 2020, Volume: 130 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Female; Fluorouracil; Humans; Male; Middle Aged; Pyridones; Pyrimidinones	2020
Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study. Oncology, 2018, Volume: 94, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biliary Tract Neoplasms; Camptothecin; Capecitabine; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Prospective Studies	2018
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 05-01, Volume: 30, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Progression-Free Survival; Survival Rate	2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. The Lancet. Oncology, 2019, Volume: 20, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Biliary Tract Surgical Procedures; Capecitabine; Chemotherapy, Adjuvant; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Time Factors; United Kingdom; Watchful Waiting	2019
Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:18 Topics: Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cetuximab; Deoxycytidine; DNA Mutational Analysis; Drug Administration Schedule; Exanthema; Fatigue; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Regression Analysis; Treatment Outcome	2013
Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma. Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cetuximab; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Prospective Studies; Survival Rate; Young Adult	2016
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Thymidine Phosphorylase; Thymidylate Synthase; Treatment Outcome	2016
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. Investigational new drugs, 2016, Volume: 34, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cohort Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Piperidines; Quinazolines; Treatment Outcome	2016
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract. BMC research notes, 2016, Mar-12, Volume: 9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome	2016
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer. American journal of clinical oncology, 2018, Volume: 41, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bile Duct Neoplasms; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Quality of Life; Survival Rate	2018
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms	2008
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-01, Volume: 26, Issue:22 Topics: Administration, Oral; Adult; Aged; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intravenous; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Pain; Pain Measurement; Palliative Care; Quality of Life; Switzerland; Time Factors; Treatment Outcome	2008
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. Oncology, 2009, Volume: 76, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Carcinoma, Pancreatic Ductal; Celecoxib; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyrazoles; Sulfonamides	2009
Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study. Pancreas, 2009, Volume: 38, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Algorithms; Antineoplastic Agents; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Immunotherapy; Interleukin-2; Isotretinoin; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms	2009
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 95, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; CA-19-9 Antigen; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Patient Compliance; Treatment Outcome	2010
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas. American journal of clinical oncology, 2012, Volume: 35, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Survival Rate; Treatment Outcome	2012
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients. Oncology, 2012, Volume: 82, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging	2012
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Biomarkers, Tumor; Capecitabine; Cholangiocarcinoma; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Statistics, Nonparametric; Treatment Outcome	2012
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study. Investigational new drugs, 2013, Volume: 31, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Demography; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Niacinamide; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Phenylurea Compounds; Sorafenib; Treatment Outcome; Wisconsin	2013
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bone Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome	2004
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer, 2005, Dec-15, Volume: 104, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Biopsy, Needle; Bone Neoplasms; Capecitabine; Carcinoma, Ductal; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gemcitabine; Humans; Immunohistochemistry; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome	2005
Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma. Cancer, 2006, Jan-15, Volume: 106, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Treatment Outcome	2006
Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Recurrence; Survival Analysis	2007
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer, 2007, Sep-15, Volume: 110, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome	2007
Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 2007, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Middle Aged; Pilot Projects	2007
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. British journal of cancer, 2008, Jan-29, Volume: 98, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Survival Analysis; Treatment Outcome	2008

Other Studies

18 other study(ies) available for capecitabine and Biliary Tract Cancer

Article	Year
Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 11-01, Volume: 40, Issue:31 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Humans	2022
Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biliary Tract Neoplasms; Capecitabine; Fluorouracil; Humans; Retrospective Studies; Treatment Outcome	2023
Treatment patterns and survival in older adults with unresected nonmetastatic biliary tract cancers. Journal of geriatric oncology, 2023, Volume: 14, Issue:3 Topics: Aged; Aged, 80 and over; Biliary Tract Neoplasms; Capecitabine; Chemoradiotherapy; Humans; Medicare; Prospective Studies; Treatment Outcome; United States	2023
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada. Current oncology (Toronto, Ont.), 2023, 07-25, Volume: 30, Issue:8 Topics: Biliary Tract Neoplasms; Canada; Capecitabine; Cisplatin; Gemcitabine; Humans	2023
Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2020, Volume: 52, Issue:10 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Case-Control Studies; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Gemcitabine; Humans; Oxaliplatin; Survival Analysis	2020
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:5 Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Humans; Irinotecan; Leucovorin; Medical Oncology; Neoadjuvant Therapy; Neoplasm Staging; Oxaliplatin; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Quality of Life; Societies, Medical; Spain	2021
Capecitabine Extends Survival for Biliary Tract Cancer. Cancer discovery, 2017, Volume: 7, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Humans; Neoplasm Staging; Treatment Outcome	2017
Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer. Chemotherapy, 2017, Volume: 62, Issue:6 Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Nausea; Neoplasm Staging; Odds Ratio; Retrospective Studies	2017
Adjuvant capecitabine in biliary tract cancer: a standard option? The Lancet. Oncology, 2019, Volume: 20, Issue:5 Topics: Biliary Tract Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Humans	2019
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Hyperbilirubinemia; Liver Diseases; Male; Middle Aged; Pancreatic Neoplasms	2014
Gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective cohort study. Chemotherapy, 2013, Volume: 59, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Cohort Studies; Deoxycytidine; Drug Therapy, Combination; Female; Fluorouracil; Gemcitabine; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Staging; Retrospective Studies; Treatment Outcome	2013
Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer. Anti-cancer drugs, 2015, Volume: 26, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis	2015
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer. Anti-cancer drugs, 2016, Volume: 27, Issue:2 Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Capecitabine; Esophageal Neoplasms; Esophagogastric Junction; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Upper Gastrointestinal Tract	2016
Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer. Asia-Pacific journal of clinical oncology, 2017, Volume: 13, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Treatment Outcome	2017
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients. British journal of cancer, 2017, Feb-28, Volume: 116, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Pyrimidines; Retrospective Studies; Survival Rate; Treatment Outcome	2017
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study. BMC cancer, 2008, Dec-18, Volume: 8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Palliative Care; Pyrimidinones; Retrospective Studies; Tegafur; Treatment Outcome; Uracil	2008
Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine. Anticancer research, 2009, Volume: 29, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Endonucleases; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein	2009
Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study. Chemotherapy, 2012, Volume: 58, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; CA-19-9 Antigen; Capecitabine; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies	2012